EOM’s Oncology Spend Reduction: A VC/PE Investment Thesis?
Specialty care is often touted as the next frontier for value-based care (VBC) models, promising significant cost reductions and improved patient outcomes. Yet, oncology, with…
Specialty care is often touted as the next frontier for value-based care (VBC) models, promising significant cost reductions and improved patient outcomes. Yet, oncology, with…
Artificial intelligence predictive models, while promising, are essentially useless in value-based care contracts if payers do not trust their underlying validation. For healthcare IT and…
The Medicaid market, with its immense scale and critical mission, represents a substantial, yet complex, frontier for digital health innovation. While the promise of AI-driven…
The promise of artificial intelligence in health is immense, particularly in its potential to bend the cost curve and improve patient outcomes. Yet, for employers…
The persistent crisis of maternal mortality and morbidity in the United States, particularly among underserved populations, has reached a critical juncture. With healthcare costs spiraling…
The healthcare AI landscape is bifurcated, presenting distinct investment durability and value propositions. On one side, population health AI platforms are demonstrating verifiable economic impact,…
The field of primary care investment is undergoing a deep transformation, driven by the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s new Making…
The Complete Care for Joint Replacement (CJR) model, launched by the CMS Innovation Center, represented a key shift in Medicare’s approach to bundled payments, transforming…
The field of value-based care is continually reshaped by federal initiatives designed to address critical healthcare gaps while simultaneously driving efficiency and improving patient outcomes.…
The administrative burden of manual prior authorization has long been a source of friction in specialty care, creating bottlenecks that delay necessary treatments and inflate…